Synthesis of 1,2,4-triazine derivatives as potential anti-anxiety and anti-inflammatory agents. 2009

Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard (Hamdard University) Hamdard Nagar, New Delhi-1 10062, India. poojamullick7@rediffmail.com

A series of 1,2,4-triazine derivatives Va (1-24) and Vb (1-24) were synthesized and evaluated for their anti-anxiety and anti-inflammatory activities. The structures of the synthesized compounds were confirmed on the basis of their spectral data. Many of the triazine compounds were found to possess good activity. Especially, compounds bearing the sulfur atom showed better activity than those bearing the oxygen atom.

UI MeSH Term Description Entries
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
January 2004, Arzneimittel-Forschung,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
November 2007, Archiv der Pharmazie,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
June 2010, Bioorganic & medicinal chemistry,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
February 2005, The Journal of pharmacy and pharmacology,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
March 1982, Il Farmaco; edizione scientifica,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
June 2021, Bioorganic chemistry,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
March 1988, Die Pharmazie,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
March 2022, Molecules (Basel, Switzerland),
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
June 2020, Bioorganic & medicinal chemistry,
Pooja Mullick, and Suroor A Khan, and Tauseef Begum, and Surajpal Verma, and Darpan Kaushik, and Ozair Alam
February 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!